Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0–I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer

References

• SauerRBeckerHHohenbergerWGerman Rectal Cancer Study GroupPreoperative versus postoperative chemoradiotherapy for rectal cancerNew Engl J Med2004351171731174015496622
   PubMed Web of Science ®Google Scholar
• SauerRLierschTMerkelSPreoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 yearsJ Clin Oncol201230161926193322529255
   PubMed Web of Science ®Google Scholar
• RodelCLierschTBeckerHPreoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trialLancet Oncol201213767968722627104
   PubMed Web of Science ®Google Scholar
• NCCNNCCN Clinical Practice Guidelines in Oncology Rectal Cancer Version 32017Fort Washington, PANCCN Available from: https://wwwnccnorg/professionals/physician_gls/pdf/rectal.pdfAccessed July 19, 2018
   Google Scholar
• ParkIJYouYNAgarwalANeoadjuvant treatment response as an early response indicator for patients with rectal cancerJ Clin Oncol201230151770177622493423
   PubMed Web of Science ®Google Scholar
• Habr-GamaAPerezRONadalinWOperative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term resultsAnn Surg20042404711717 discussion 717–71815383798
   PubMed Web of Science ®Google Scholar
• GerardJPChamoreyEGourgou-BourgadeSClinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trialRadiother Oncol2015115224625225921382
   PubMed Web of Science ®Google Scholar
• MaasMBeets-TanRGLambregtsDMWait-and-see policy for clinical complete responders after chemoradiation for rectal cancerJ Clin Oncol201129354633464022067400
   PubMed Web of Science ®Google Scholar
• WolthuisAMPenninckxFHaustermansKEctorsNVan CutsemED’HooreAOutcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiationAnn Surg Oncol201118368469020842458
   PubMed Web of Science ®Google Scholar
• LeeLKellyJNassifGJChemoradiation and local excision for T2N0 rectal cancer offers equivalent overall survival compared to standard resection: a National Cancer Database analysisJ Gastrointest Surg201721101666167428819913
   PubMed Web of Science ®Google Scholar
• ShinYSYoonYSLimSBPreoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancerRadiat Oncol J201634317718527730804
   PubMedGoogle Scholar
• Vukobrat-BijedicZHusic-SelimovicASoficACancer antigens (CEA and CA 19-9) as markers of advanced stage of colorectal carcinomaMed Arch201367639740125568506
   PubMedGoogle Scholar
• ZhangSYLinMZhangHBDiagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinomaInt J Clin Exp Pathol2015889404940926464695
   PubMed Web of Science ®Google Scholar
• DressenKHermannNManekellerSDiagnostic performance of a novel multiplex immunoassay in colorectal cancerAnticancer Res20173752477248628476816
   PubMed Web of Science ®Google Scholar
• Moureau-ZabottoLFarnaultBde ChaisemartinCPredictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancerInt J Radiat Oncol Biol Phys201180248349121093174
   PubMed Web of Science ®Google Scholar
• FarnaultBMoureau-ZabottoLde ChaisemartinCPredictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survivalCancer Radiother2011154279286 French21515083
   PubMed Web of Science ®Google Scholar
• YeoSGKimDYKimTHCarbohydrate antigen 19-9 levels associated with pathological responses to preoperative chemoradiotherapy in rectal cancerAsian Pac J Cancer Prev201415135383538725041006
   PubMedGoogle Scholar
• XuBChenYGuoYPretreatment tumor thickness as a predictor of pathologic complete response to neoadjuvant chemoradiation therapy for stage II/III rectal adenocarcinomaAm J Clin Oncol201841660160627672742
   PubMed Web of Science ®Google Scholar
• JuulTBattersbyNJChristensenPValidation of the English translation of the low anterior resection syndrome scoreColorectal Dis2015171090891625807963
   PubMed Web of Science ®Google Scholar
• Garcia-AguilarJRenfroLAChowOSOrgan preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trialLancet Oncol201516151537154626474521
   PubMed Web of Science ®Google Scholar
• VerseveldMde GraafEJVerhoefCChemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)Br J Surg2015102785386025847025
   PubMed Web of Science ®Google Scholar
• ShinYSYuCSParkJHTotal mesorectal excision versus local excision after favorable response to preoperative chemoradiotherapy in “Early” clinical T3 rectal cancer: a propensity score analysisInt J Radiat Oncol Biol Phys201799113614428816139
   PubMed Web of Science ®Google Scholar
• PerezROHabr-GamaASao JuliaoGPTransanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation – does baseline staging matter?Dis Colon Rectum201457111253125925285691
   PubMed Web of Science ®Google Scholar
• WallinURothenbergerDLowryALuepkerRMellgrenACEA – a predictor for pathologic complete response after neoadjuvant therapy for rectal cancerDis Colon Rectum201356785986823739192
   PubMed Web of Science ®Google Scholar
• RestivoAZorcoloLCoccoIMElevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancerAnn Surg Oncol201320386487123010737
   PubMed Web of Science ®Google Scholar
• LiQWZhengRLLingYHPrediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective studyAbdom Radiol (New York)201641814481455
   PubMed Web of Science ®Google Scholar
• YeoSGKimDYChangHJReappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapyTumori2013991939923549007
   PubMed Web of Science ®Google Scholar
• BuijsenJvan StiphoutRGMenheerePPLammeringGLambinPBlood biomarkers are helpful in the prediction of response to chemo-radiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancerRadiother Oncol2014111223724224746569
   PubMed Web of Science ®Google Scholar
• YangKLYangSHLiangWYCarcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgeryRadiat Oncol201384323452434
   PubMed Web of Science ®Google Scholar
• MikiHAkiyoshiTOguraAPretreatment serum carbohydrate antigen 19–9 concentration is a predictor of survival of patients who have undergone curative resection of stage IV rectal cancerDig Surg Epub201791
   PubMed Web of Science ®Google Scholar
• ZhangLNOuYangPYXiaoWWElevated CA19-9 as the most significant prognostic factor in locally advanced rectal cancer following neoadjuvant chemoradiotherapyMedicine20159445e179326559251
   PubMed Web of Science ®Google Scholar
• ZhangLNXiaoWWXiSYPathological assessment of the AJCC tumor regression grading system after preoperative chemoradiotherapy for Chinese locally advanced rectal cancerMedicine2016953e227226817863
   PubMed Web of Science ®Google Scholar